185 related articles for article (PubMed ID: 32761885)
1. Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review.
Goda JS; Gaikwad U; Narayan A; Kurkure D; Yadav S; Khanna N; Jain H; Bagal B; Epari S; Singh P; Sengar M; Laskar S
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1264. PubMed ID: 32761885
[TBL] [Abstract][Full Text] [Related]
2. Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.
Cubo AM; Soto ZM; Cruz MÁ; Doyague MJ; Sancho V; Fraino A; Blanco Ó; Puig N; Alcoceba M; González M; Sayagués JM
Medicine (Baltimore); 2017 May; 96(19):e6846. PubMed ID: 28489772
[TBL] [Abstract][Full Text] [Related]
3. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
[TBL] [Abstract][Full Text] [Related]
4. Malignant lymphoma of the uterine cervix: a case report and review of literature.
Biswal BM; Sharma A; Sharma MC; Prasad RR; Roy K; Rath GK
J Indian Med Assoc; 1997 Jul; 95(7):434, 440. PubMed ID: 9425847
[No Abstract] [Full Text] [Related]
5. Primary lymphoma of the uterus and cervix: two case reports and review of the literature.
Upanal N; Enjeti A
Aust N Z J Obstet Gynaecol; 2011 Dec; 51(6):559-62. PubMed ID: 21923699
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma.
Lee GW; Go SI; Kim SH; Hong J; Kim YR; Oh S; Kim SY; Do YR; Lee H; Lee SI; Bae SH; Oh SY; Song MK; Lee WS; Lee B; Kim JS; Kim MK; Kang HJ; Ahn JS; Yhim HY; Kim HJ; Kim SJ; Kim WS; Suh C;
Leuk Lymphoma; 2015 Apr; 56(4):1020-6. PubMed ID: 25039351
[TBL] [Abstract][Full Text] [Related]
7. A case of primary non-Hodgkin's lymphoma of the uterine cervix treated by combination chemotherapy (THP-COP).
Nasu K; Yoshimatsu J; Urata K; Miyakawa I
J Obstet Gynaecol Res; 1998 Apr; 24(2):157-60. PubMed ID: 9631606
[TBL] [Abstract][Full Text] [Related]
8. Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy.
Li C; Ma X; Pan Z; Lv F; Xia Z; Xue K; Zhang Q; Ji D; Cao J; Hong X; Guo Y
Leuk Res; 2018 Nov; 74():80-85. PubMed ID: 30316031
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.
Lee S; Yamauchi T; Kinoshita K; Imamura S; Kamiya K
J Clin Exp Hematop; 2017 Oct; 57(2):64-68. PubMed ID: 28883219
[TBL] [Abstract][Full Text] [Related]
10. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 years.
Liu YC; Gau JP; Yu YB; Hong YC; Yen CC; Liu CY; Chao TC; Hsiao LT; Liu JH; Chiou TJ; Tzeng CH
Intern Med; 2014; 53(2):95-101. PubMed ID: 24429447
[TBL] [Abstract][Full Text] [Related]
12. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M; Kuhnt E; Trümper L; Osterborg A; Trneny M; Shepherd L; Gill DS; Walewski J; Pettengell R; Jaeger U; Zinzani PL; Shpilberg O; Kvaloy S; de Nully Brown P; Stahel R; Milpied N; López-Guillermo A; Poeschel V; Grass S; Loeffler M; Murawski N;
Lancet Oncol; 2011 Oct; 12(11):1013-22. PubMed ID: 21940214
[TBL] [Abstract][Full Text] [Related]
13. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
14. Primary lymphoma of the cervix uteri: a diagnostic challenge. Report of two cases and review of the literature.
Van Renterghem N; De Paepe P; Van den Broecke R; Bourgain C; Serreyn R
Eur J Gynaecol Oncol; 2005; 26(1):36-8. PubMed ID: 15754997
[TBL] [Abstract][Full Text] [Related]
15. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
16. Relapse in stage I(E) diffuse large B-cell lymphoma.
Nijland M; Boslooper K; van Imhoff G; Kibbelaar R; Joosten P; Storm H; van Roon EN; Diepstra A; Kluin-Nelemans HC; Hoogendoorn M
Hematol Oncol; 2018 Apr; 36(2):416-421. PubMed ID: 29083044
[TBL] [Abstract][Full Text] [Related]
17. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Récher C; Coiffier B; Haioun C; Molina TJ; Fermé C; Casasnovas O; Thiéblemont C; Bosly A; Laurent G; Morschhauser F; Ghesquières H; Jardin F; Bologna S; Fruchart C; Corront B; Gabarre J; Bonnet C; Janvier M; Canioni D; Jais JP; Salles G; Tilly H;
Lancet; 2011 Nov; 378(9806):1858-67. PubMed ID: 22118442
[TBL] [Abstract][Full Text] [Related]
18. [Non-Hodgkin's lymphoma of the uterus: apropos of 4 cases and review of the literature].
el Omari-Alaoui H; Kebdani T; Benjaafar N; el Ghazi E; Erriahni H; el Gueddari BK
Cancer Radiother; 2002 Feb; 6(1):39-45. PubMed ID: 11899679
[TBL] [Abstract][Full Text] [Related]
19. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
20. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
